Companies /Healthcare

Johnson & Johnson

NYSE: JNJ Drug Manufacturers - General
$255.56
▲ $2.28 (+0.90%) today
Markets closed · 8:15am ET

JNJ Coverage Page 48

11:40am ET
Health and Healthcare

Why Arrowhead Pharma’s New Agreement Is a Big Deal

Arrowhead Pharmaceuticals shares stumbled on Thursday after it announced a license and collaboration agreement with Janssen Pharmaceutica, a subsidiary of Johnson & Johnson.

JNJ
Chris Lange